There is one clinical trial.

Clinical Trials

1 Clinical Characterisation Protocol for COVID-19 in People Living With HIV

There is very little data so far to determine whether people living with HIV (PLWHIV) are at greater risk of COVID-19 acquisition or severe disease. HIV infection is associated with deficiencies in both humoral and cell-mediated immunity that could potentially alter the course and severity of common infections. The investigators will study the correlation between clinical and immunovirological data. The singularity of this work is to have an in-depth immunovirological approach linked to the clinical characteristics in COVID-19 HIV co-infected patients. COVIDHIV is the only study to date to offer this combined approach in PLWHIV. This protocol is a historical and prospective cohort study of PLWHIV presenting COVID-19 The primary objectives are to describe the course of COVID-19 disease in patients infected with HIV

NCT04361604 Adult Patients Living With HIV (PLWHIV) With Confirmed Infection With SARS-CoV-2 Since 1st January 2020 Biological: Biological collection (patients co infected HIV Sras-CoV-2) Other: Auto-questionnaires (patients co infected HIV Sras-CoV-2) Other: Qualitative interviews (in 40 patients : 20 with COVID-19 and 20 without COVID-19)

No related HPO nodes (Using clinical trials)